Opus Genetics (IRD) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.73% |
| Dec 31, 2025 | 0.84% |
| Sep 30, 2025 | 35.35% |
| Jun 30, 2025 | 29.27% |
| Mar 31, 2025 | 32.98% |
| Dec 31, 2024 | 12.23% |
| Sep 30, 2024 | 20.29% |
| Jun 30, 2024 | 21.09% |
| Mar 31, 2024 | 62.30% |
| Dec 31, 2023 | 45.04% |
| Sep 30, 2023 | 83.06% |
| Jun 30, 2023 | 61.86% |
| Mar 31, 2023 | 57.81% |
| Dec 31, 2022 | 201.70% |
| Sep 30, 2022 | -0.93% |
| Jun 30, 2022 | 0.42% |
| Mar 31, 2022 | 1.79% |
| Dec 31, 2021 | 17.58% |
| Sep 30, 2021 | 18.70% |
| Jun 30, 2021 | 11.46% |
| Mar 31, 2021 | -18.69% |
| Dec 31, 2020 | -14.50% |
| Sep 30, 2020 | -28.91% |
| Jun 30, 2020 | -28.55% |
| Mar 31, 2020 | -16.13% |
| Dec 31, 2019 | -56.07% |
| Sep 30, 2019 | -12.99% |
| Jun 30, 2019 | -4.86% |
| Mar 31, 2019 | -8.74% |
| Dec 31, 2018 | -13.52% |
| Sep 30, 2018 | -15.60% |
| Jun 30, 2018 | -12.66% |
| Mar 31, 2018 | -9.55% |
| Dec 31, 2017 | -5.51% |
| Sep 30, 2017 | -12.30% |
| Jun 30, 2017 | -10.54% |
| Mar 31, 2017 | -21.91% |
| Dec 31, 2016 | 2.47% |
| Sep 30, 2016 | 12.26% |
| Jun 30, 2016 | 22.85% |
| Mar 31, 2016 | 24.16% |
| Dec 31, 2015 | 18.47% |
| Sep 30, 2015 | 42.48% |
| Jun 30, 2015 | 41.02% |
| Mar 31, 2015 | 37.56% |
| Dec 31, 2014 | 34.80% |
| Sep 30, 2014 | 24.94% |
| Jun 30, 2014 | 21.51% |
| Dec 31, 2013 | 6.44% |